Crateva adansonii is a medicinal herb commonly used in parts of Africa because
of the side effects of Non-Steroidal Anti-inflammatory Drugs (NSAID), like heart
diseases and kidney failure. Inflammation is a major public heart issue in the world
but treatment is becoming complex because of the side effects of anti-
inflammatory pharmaceutical drugs. Hence the need for alternative drug is highly
required. This research work investigated the anti-inflammatory activity of
dichloromethane fraction of methanol extract of Crateva adansonii stem bark,
using rodent model. Adult Swiss albino rats (110-200g) of either sex were
randomlydivided into 5 groups of 4 animals each. Groups 2, 3, 4, and 5 received
different doses of the extract (300mg, 500mg, 700mg, and 900mg) in 3% v/v
tween 80 administered intraperitonally respectively. Control group-1 received
volume of 3%v/v tween 80 and standards group received 100mg/kg Ibuprofen.
One hour later acute inflammation was induced by injection of 0.1ml of undiluted
egg albumin into the sub planter of the right hand paw of rats. The volume of the
paw was measured by mercury displacement before and at 0.5, 1, 1.5, 2, 2.5 & 3
hours after egg albumin injection, while the standard was measured at internals of
one hour, for up to 4 hours. Edema formation was assessed in terms of the
difference in the zero time per volume of the injected pair and its volume at the
different time after egg albumin injection. For each dose of extract, percentage
inhibition of edema was calculated percentage inhibition. Result show that Crateva
adansonii may have anti-inflammatory effects. This finding supports the use stem
bark of Crateva adansonii in not only traditional medicine for the treatment of
inflammation.
Title page
Approval page
Dedication
Acknowledgment
Abstract
Table of Content
CHAPTER ONE
1.0 Introduction
1.1 Crateva adansonii
1.2 Research Aim & Objectives
CHAPTER TWO
2.1 Definition of Inflammation
2.1.1 What is Anti-inflammation?
Types of Inflammation (Acute and Chronic)
2.1.2 Steroid and non-steroidal anti-inflammatory drugs
2.1.3 Immune selective anti-inflammatory derivative
2.1.4 Pain
2.1.5 Long effect of inflammation
2.1.6 Ice Treatment of Inflammation
2.1.7 Nutritional sources of anti-inflammatory compounds
2.2 Vascular event in inflammation
2.2.1 Vasoconstriction
2.2.2 Vasodilation
2.2.3 Vascular permeability
2.3 Cellular event
2.3.1 Leukocytes migration as specific
Hemoral/cellular immunity
2.4 Mediators of inflammation
2.4.1 Cell derived mediators of inflammation
2.4.2 Histamine
2.4.3 Cytokines
2.4.4 Serotonin (5-hydroxytryptamine)
2.4.5 Platelet-Activating factor (PAF)
2.4.6 Arachidonic Acid (AA
2.4.7 Free radicals as mediators of inflammation
2.4.8 Nitric Acid (NO)
2.4.9 Reactive Oxygen Species (ROS)
CHAPTER THREE
3.1 Materials, equipments and apparatus
3.2 Chemical, reagents and practical technique
3.2.1 Methanol
3.2.2 N-Hexane
3.2.3 Ethyl acetate
3.2.4 Dichloromethane
3.3 Methodology
3.3.1 Collection and preparation of plant
3.3.2 Extraction and fractionation of plant materials
3.4 Phytochemical Analysis
3.5 Column chromatography
3.6 Thin layer chromatography
3.7 How to run TCL plate
CHAPTER FOUR
4.0 Experimental result
4.1 Tabular and graphical representation of effect of anti-inflammatory effect of
Crateva adansonii dichloromethane extract
4.2 Phytochemical analysis of extract (result)
CHAPTER FIVE
5.0 Discussion
5.1 Conclusion
REFERENCE
APPENDIX I
APPENDIX II
APPENDIX III
APPENDIX IV
APPENDIX V
Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction. (n.d.). UniTopics. https://www.unitopics.com/project/material/anti-inflammatory-activity-of-crateva-adansonii-dlchloromethane-fraction/
“Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction.” UniTopics, https://www.unitopics.com/project/material/anti-inflammatory-activity-of-crateva-adansonii-dlchloromethane-fraction/. Accessed 22 November 2024.
“Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction.” UniTopics, Accessed November 22, 2024. https://www.unitopics.com/project/material/anti-inflammatory-activity-of-crateva-adansonii-dlchloromethane-fraction/
Here’s a typical structure for Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction research projects:
- The title page of Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction should include the project title, your name, institution, and date.
- The abstract of Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction should be a summary of around 150-250 words and should highlight the main objectives, methods, results, and conclusions.
- The introduction of Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction should provide the background information, outline the research problem, and state the objectives and significance of the study.
- Review existing research related to Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction, identifying gaps the study aims to fill.
- The methodology section of Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction should describe the research design, data collection methods, and analytical techniques used.
- Present the findings of the Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction research study using tables, charts, and graphs to illustrate key points.
- Interpret Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction results, discussing their implications, limitations, and potential areas for future research.
- Summarize the main findings of the Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction study and restate its significance.
- List all the sources you cited in Anti-Inflammatory Activity Of Crateva adansonii Dlchloromethane fraction project, following a specific citation style (e.g., APA, MLA, Chicago).